The impact of direct‐acting antivirals on hepatitis C viraemia among people who inject drugs in England; real‐world data 2011–2018

Direct‐acting antiviral (DAA) therapy for anybody with viraemic HCV infection has been scaled‐up in England since 2017. To assess early impacts, we investigated trends in, and factors associated with, HCV viraemia among people who inject drugs (PWID). We also examined trends in self‐reported treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardsley, Megan, Heinsbroek, Ellen, Harris, Ross, Croxford, Sara, Edmundson, Claire, Hope, Vivian, Hassan, Nasra, Ijaz, Samreen, Mandal, Sema, Shute, Justin, Hutchinson, Sharon J., Hickman, Matthew, Sinka, Katy, Phipps, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290701/
https://www.ncbi.nlm.nih.gov/pubmed/34270172
http://dx.doi.org/10.1111/jvh.13575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290701/
https://www.ncbi.nlm.nih.gov/pubmed/34270172
http://dx.doi.org/10.1111/jvh.13575

Ejemplares similares